Peptide Design Boosts Drug Efficacy
A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug ...
PharmaTimes11 天
Oxford Drug Design achieves in vivo validation for novel cancer treatment
Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its ...
drugtargetreview.com6 天
FDA’s Project Optimus: A new era in oncology drug dosing
Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.
BioWorld10 天
Oxford Drug Design validates novel approach in mouse model of colorectal cancer
Oxford Drug Design Ltd. has announced additional in vivo validation for its novel approach against cancer. The innovative approach, using generative AI capabilities, is based on the novel target ...
PharmiWeb11 天
Oxford Drug Design achieves further in vivo validation of novel approach against multiple ...
Oxford Drug Design, the Oxford-based AI drug discovery company, has today announced additional in vivo validation for its first-in-class approach against cancer as the Company continues to apply its ...